The EMA Launches new PRIority Medicines scheme – PRIME

The EMA Launches new PRIority Medicines scheme – PRIME

The European Medicines Agency has today launched the new PRIME (PRIority MEdicines) scheme to strengthen support for medicines that target an unmet medical need. The scheme focuses on medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients with no treatment options.

A press release and further information on PRIME have been published on the EMA website, including details of how to apply.…